During the past decade, Koffler Vision Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Koffler Vision Group" #1 sponsor was "Shire" with 3 trials, followed by "Eye and Vision Technologies and Research Institute" with 1 trials sponsored, "Kala Pharmaceuticals, Inc." with 1 trials sponsored, "Koffler Vision Group" with 1 trials sponsored and "Merck Sharp & Dohme LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Koffler Vision Group" #1 collaborator was "Fera Pharmaceuticals, LLC" with 1 trials as a collaborator and "ZeaVision, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Koffler Vision Group" are "Adenoviral Conjunctivitis" (1 trials), "Allergic Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Blepharitis" (1 trials) and "Dry Eye Disease" (1 trials). Many other conditions were trialed in "Koffler Vision Group" in a lesser frequency.

Most popular intervention types in "Koffler Vision Group" are "Drug" (7 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials), "Azithromycin ophthalmic solution, 1%" (1 trials) and "KPI-121 0.25% Ophthalmic Suspension" (1 trials). Other intervention names were less common.

The vast majority of trials in "Koffler Vision Group" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Koffler Vision Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Koffler Vision Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Koffler Vision Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".